Science Explorer Interactive view Map
Company · Bielefeld · Germany

Apocare Pharma (Germany)

apocarepharma.de/index.php/enROR OpenAlex
Research works
26
▼ 27% vs 2013–17
Citations
274
10.5 per fractional work
Top-10% rate
10.5%
record average 16.5%
Open access
32%
world 28%

Not ranked overall: Apocare Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.08× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.97× its world share, 0 worksImmunology and Micro…Neuroscience: 2.47× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 17.05× its world share, 0 worksPharmacology, Toxico…Energy: 1.63× its world share, 0 worksEnergyEngineering: 0.14× its world share, 0 worksEngineeringEnvironmental Science: 0.54× its world share, 0 worksEnvironmental ScienceHealth Professions: 1.35× its world share, 0 worksHealth ProfessionsMedicine: 1.82× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 0.70× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.1×. Every wedge is a field page.

Which keywords describe research at Apocare Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Reactive Oxygen Species, Photodynamic Therapy, Nanoparticles, Cancer Treatment, Antimicrobial, Drug Discovery, Photosensitizers and Singlet Oxygen.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 25 words, with their numbers
  1. Reactive Oxygen Species3▲ 22×5 topics
  2. Nanoparticles2▲ 6.8×2 topics
  3. Photodynamic Therapy2▲ 57×2 topics
  4. Cancer Treatment2▲ 29×3 topics
  5. Antimicrobial2▲ 28×2 topics
  6. Oxidative Stress2▲ 3.6×7 topics
  7. Clinical Trials2▲ 9.6×2 topics
  8. Drug Discovery2▲ 15×6 topics
  9. Photosensitizers2▲ 252×1 topic
  10. Singlet Oxygen2▲ 252×1 topic
  11. Adverse Drug Reactions2▲ 87×2 topics
  12. Off-Label Drug Use1▲ 142×1 topic
  13. Pediatric Pharmacokinetics1▲ 142×1 topic
  14. Glycosylation1▲ 23×2 topics
  15. Immunotherapy1▲ 7.7×3 topics
  16. Chemotherapy1▲ 6.7×7 topics
  17. Diagnosis1▲ 4.7×6 topics
  18. Epidemiology1◆ 1.13×8 topics
  19. Monoclonal Antibody1▲ 64×2 topics
  20. Treatment1▲ 3.6×6 topics
  21. Anticancer Agents1▲ 16×4 topics
  22. Inflammation1▲ 1.83×6 topics
  23. Medicinal Chemistry1▲ 11×4 topics
  24. Monoclonal Antibodies1▲ 28×2 topics
  25. Therapeutic Antibodies1▲ 31×2 topics

Which research topics does Apocare Pharma (Germany) publish most on?

By volume in 2022–2025: Molecular Biology Techniques and Applications, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Protein Degradation and Inhibitors.

Molecular Biology Techni…0Molecular Biology Techniques and Applications: 0 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksMicroRNA in disease regulation: 0 fractional worksProtein Tyrosine Phospha…0Protein Tyrosine Phosphatases: 0 fractional worksAtherosclerosis and Cardiovascular Diseases: 0 fractional worksBioactive Compounds and Antitumor Agents: 0 fractional works
Molecular BiologyGeneticsPathology and Forensic MedicineRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Molecular Biology Techniques and Applications Molecular Biology 0 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 0 works
  3. 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 0 works
  5. 5 Ubiquitin and proteasome pathways Molecular Biology 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 MicroRNA in disease regulation Cancer Research 0 works
  8. 8 Protein Tyrosine Phosphatases Molecular Biology 0 works
  9. 9 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
  10. 10 Bioactive Compounds and Antitumor Agents Toxicology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.5%not open67.5%

World: 28% of research is openly available.

with international co-authors19.3%domestic only80.7%

World: 19% is written across borders.

How has Apocare Pharma (Germany)'s research output changed?

Output in 2018–2022 was 27% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bielefeld

All research institutions in Bielefeld

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.